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Abstract
Background: B-lines evaluated by lung ultrasound (LUS) are the sonographic sign of pulmonary congestion, a
major predictor of morbidity and mortality in patients with heart failure (HF). Our aim was to assess the prognostic
value of B-lines at discharge to predict rehospitalization at 6 months in patients with acute HF (AHF).
Methods: A prospective cohort of 100 patients admitted to a Cardiology Department for dyspnea and/or clinical
suspicion of AHF were enrolled (mean age 70 ± 11 years). B-lines were evaluated at admission and before discharge.
Subjects were followed-up for 6-months after discharge.
Results: Mean B-lines at admission was 48 ± 48 with a statistically significant reduction before discharge (20 ± 23,
p < .0001). During follow-up, 14 patients were rehospitalized for decompensated HF. The 6-month event-free survival
was highest in patients with less B-lines (≤ 15) and lowest in patients with more B-lines (> 15) (log rank
χ2 20.5, p < .0001). On multivariable analysis, B-lines > 15 before discharge (hazard ratio [HR] 11.74; 95 % confidence
interval [CI] 1.30–106.16) was an independent predictor of events at 6 months.
Conclusions: Persistent pulmonary congestion before discharge evaluated by ultrasound strongly predicts
rehospitalization for HF at 6-months. Absence or a mild degree of B-lines identify a subgroup at extremely low risk to
be readmitted for HF decompensation.
Keywords: Lung ultrasound, B-lines, Ultrasound lung comets, Pulmonary congestion, Prognosis,
Rehospitalization
Introduction
Heart failure (HF) afflicts 1–2 % of people in the western
world, with an incidence of 5–10 per 1000 persons per year
[1]. Acute heart failure (AHF) is the most common reason
for hospitalization in patients aged > 65 years [2, 3]. Despite
significant improvement in signs and symptoms during
hospitalization, post-discharge outcomes for patients hospi-
talized for AHF are poor. Up to 25 % of AHF patients are
readmitted within 30 days of discharge, with a high mortal-
ity rate during this period [4].
Pulmonary congestion is a major predictor of morbid-
ity and mortality in HF [5]. It is the single most import-
ant contributor to hospitalization, more significant than
a low cardiac output [6]. Congestion is often not ad-
equately addressed during hospitalization; patients ex-
perience improved symptoms, and may be free of
clinical congestion but have persistent hemodynamic or
pulmonary congestion [5, 7–9]. Failure to adequately re-
lieve congestion during hospitalization is associated
with increased morbidity and mortality, whereas pa-
tients discharged without congestion show better out-
comes [10, 11].
Lung ultrasound (LUS) is a simple, accurate, and
patient-friendly tool to assess pulmonary congestion, by
evaluation of B-lines (previously called ultrasound lung
comets) [12, 13]. B-lines are the sonographic sign of the
pulmonary interstitial syndrome, representing the pul-
monary interstitial edema in patients with AHF. Many
studies have shown their utility in the differential diag-
nosis of acute dyspnea [14–20]. As such, assessment of
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B lines is now recommended in the pre-hospital and
hospital management of AHF, as a bedside tool to en-
able direct visualization of interstitial edema in patients
with suspected AHF [21]. Fewer studies are available on
the prognostic role of pulmonary congestion assessed
by B-lines, especially at discharge.
The aim of our study was to assess the prognostic
significance of pulmonary congestion at discharge, as
assessed by LUS B-lines, in patients admitted to a
Cardiology Department with a suspicion of AHF. The
study hypothesis is that in patients with detectable




A prospective cohort of 118 patients admitted to a
Cardiology Department at a single center were enrolled.
The inclusion criterion was the presence of signs and/or
symptoms of AHF, irrespective of the etiology. Exclusion
criteria were: 1) Inability to provide informed consent; 2)
Known history of pulmonary fibrosis, pneumothorax,
fibrothorax, lung cancer; 3) Patients not discharged
home, but transferred to another department. From the
initial population, 5 patients were excluded: 2 for known
pulmonary fibrosis (1 patient with systemic sclerosis and
1 patient with post-irradiation thoracic fibrosis), 1 for
fibrothorax, 1 for lung cancer, and 1 because she was
transferred to another department and not discharged
home.
The local Ethical Committee approved the protocol and
all patients gave informed consent. The study conforms to
the principles outlined in the Declaration of Helsinki.
Lung ultrasound
Experienced sonographers (cardiologists and technicians
accredited in transthoracic echocardiography by the
European Association of Cardiovascular Imaging) per-
formed the LUS examinations. LUS was performed twice
in all patients: the first evaluation was done at admission
at the end of standard echocardiography. The second
evaluation was performed before discharge at the end of
echocardiography, in case a second echocardiography
was requested by the attending physicians, or as stand-
alone examination. Patients were in the supine or near-
to-supine position. The ultrasound scanning of the an-
terior and lateral chest was obtained as previously de-
scribed on the right and left hemithoraxes. A detailed
video showing how to perform a LUS examination to
detect B-lines can be freely accessed at the following
link: http://www.youtube.com/watch?v=amsULL ws8GI.
A B-line was defined as a discrete laser-like vertical
hyperechoic reverberation artifact that arises from the
pleural line, extends to the bottom of the screen without
fading, and moves synchronously with lung sliding [12]. In
each intercostal space, the number of B-lines was recorded,
and the sum of B-lines of each scanning sites yielded a
score denoting the extent of the pulmonary interstitial
edema. Zero was defined as a complete absence of B-lines
in a scanning site. The presence of B-lines was staged in
three grades, according to previous literature [22]: mild
(a total of 6–15 B-lines on all scanning sites), moderate
(a total of 16–30 B-lines on all scanning sites), and
severe (> 30 B-lines on all scanning sites). The LUS ex-
aminations were performed with the same probe and
same setting routinely used for echocardiographic studies.
The intra- and interobserver variability of B-lines quantifi-
cation have been previously tested in our laboratory as 5.1
and 7.4 %, respectively [23, 24]. A high reproducibility has
been reported by other studies [25, 26].
Reference standard definition of heart failure
Two cardiologists, who were blinded to the results of
LUS evaluation, reviewed all the available medical re-
cords pertaining to the patient, and made an independ-
ent assessment of the probability of the patient having
HF. Confirmation of AHF was based on the Framing-
ham criteria, with corroborative information including
clinical diary, information on hospital course, response
to diuretics and other drugs, haemodynamic monitor-
ing, electrocardiograms, chest X-ray, echocardiography,
natriuretic peptides, and results of subsequent cardiac
testing, including nuclear medicine or magnetic reson-
ance imaging. For patients with a diagnosis other than
HF, confirmation was attempted using the following var-
iables: normal chest X-ray (lack of heart enlargement
and signs of pulmonary congestion), normal systolic and
diastolic heart function by echocardiography, normal
valve function at echocardiography, normal natriuretic
peptides, hospital clinical course. In cases when the two
cardiologists failed to agree on a diagnosis, a consensus
was reached with a third expert.
Follow-up data
Follow-up data were obtained from at least 1 of 4
sources: review of the patient's hospital record, personal
communication with the patient’s physician and review
of the patient’s chart, a telephone interview with the pa-
tient conducted by trained personnel, a staff physician
visiting the patients at regular intervals in the out-
patient clinic. According to study protocol, follow-up
information were obtained at 6 months. By inclusion
criteria, follow-up data were obtained in all patients.
Events were defined as rehospitalization for AHF in the
6 months following discharge. The development or
progression of HF was defined according to the same
criteria used for the reference standard definition of HF
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at admission. Patients who died were censored at the
time of death.
Statistical analysis
Continuous variables are expressed as mean ± SD. Two-
sample comparisons were performed using t-test if vari-
ables were normally distributed, the Mann–Whitney U test
for not normally distributed data, and the chi-squared test
for categorical data. Death rates were estimated with
Kaplan-Meier curves and compared by the log-rank test.
A sample size calculation established a number of 91
patients to get an alpha error of 0.05, and a power of 0.9.
The association of selected variables with outcome was
assessed with the Cox’s proportional hazard model using
univariable and stepwise multivariable procedures. A sig-
nificance of p<0.05 was required for a variable to be in-
cluded into the multivariable model, whilst p<0.1 was the
cut-off value for exclusion. The following covariates were
analysed at multivariable analysis: NYHA class, haemoglo-
bin, NT-proBNP at discharge, B-lines at admission and at
discharge. Hazard ratios (HR) with the corresponding 95 %
confidence interval (CI) were estimated. Statistical signifi-
cance was set at p < 0.05. All analyses were conducted with
the Statistical Package for the Social Sciences (SPSS Inc.,
Chicago, Illinois, version 20) and GraphPad Prism version 6
(GraphPad Software Inc., San Diego, CA, USA).
Results
Cardiopulmonary ultrasound
Nine patients were excluded, after blinded reclassification,
because of lack of signs and symptoms of HF. One patient
was excluded because of in-hospital death. Three patients
were lost at follow-up. Clinical characteristics of the final
study population of 100 patients are shown in Table 1 and
cardiac and lung ultrasound data are shown in Table 2.
Ejection fraction was < 50 % in 74 patients; a signifi-
cant diastolic dysfunction with restrictive pattern was
present in 23 patients; 15 patients had a severe mitral
regurgitation, 1 patient had a severe mitral stenosis, 3
patients had a severe aortic stenosis and 1 patient had a
severe aortic regurgitation. The main aetiology of HF
was coronary artery disease (52 patients), dilated
cardiomyopathy (18 patients), valvular heart disease
(15 patients), hypertensive heart disease (6 patients),
arrhythmias (5 patients), hypertrophic cardiomyopathy
(3 patients), chemotherapy-related cardiomyopathy
(1 patient).
LUS scanning was feasible in 100 % of the cases and time
needed for the examination was always less than 5 min.
Mean B-lines at admission was 48 ± 48 with a statistically
significant reduction before discharge (20 ± 23, p < .0001,
Fig. 1). In 27 % of patients with a severe degree of B-lines at
admission, the attending physician did not report pulmon-
ary crackles at physical examination.
Outcomes
The patient who died during hospitalization had a severe de-
gree of B-lines in the last LUS scanning, the same day of his
death. This patient was excluded from the analysis. During
the 6-month follow-up a total of 14 rehospitalization for HF
and 4 deaths occurred. Mean follow-up was 159 ± 50 days.
A ROC analysis was performed to identify > 50 B-lines
at admission as the best cut-off to predict readmission for
HF during follow-up with a sensitivity of 71.4 %, specifi-
city of 69.8 % negative predictive value of 93.7 %, positive
predictive value of 27.8 %, negative likelihood ratio of
0.41, positive likelihood ratio of 2.36 (area under the curve
0.71, 95 % confidence interval 0.58–0.85, p = .011). A ROC
Table 1 Clinical characteristics of the study population
Patients n = 100
Male (n, %) 73 (73 %)
Age (years) 70 ± 11
NYHA class 2.9 ± 0.9
SAP (mmHg) 126 ± 24
Diabetes Mellitus (n, %) 39 (39 %)
Hypertension (n, %) 57 (57 %)
Dyslipidemia (n, %) 39 (39 %)
Current smokers (n,%) 12 (12 %)
Creatinine (mg/dl) 1.3 ± 0.6
Hemoglobin (g/dl) 12.9 ± 2.1
CRP (mg/l) 1.4 ± 2
NT-proBNP (ng/l) 5291 ± 5877
NYHA New York Heart Association, SAP systolic arterial pressure, CRP
C-reactive protein
Table 2 Cardiac and pulmonary ultrasound data of the study
population
Ejection fraction (%) 37 ± 14
Wall motion score index 1.8 ± 0.56
LV end-diastolic diameter (mm) 58 ± 10
Impaired relaxation (n, %) 20 (20 %)
Pseudonormal pattern (n, %) 11 (11 %)
Restrictive pattern (n, %) 23 (23 %)
Moderate to severe mitral valve disease (n, %) 54 (54 %)
Moderate to severe aortic valve disease (n, %) 12 (12 %)
TAPSE (mm) 16.5 ± 4.7
PASP (mmHg) 49 ± 15
Pericardial effusion (n, %) 9 (9 %)
Pleural effusion (n, %) 24 (24 %)
B-lines at admission 48 ± 48
B-lines before discharge 20 ± 23
LV left ventricular, TAPSE tricuspid annular plane systolic excursion, PASP
pulmonary artery systolic pressure
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analysis was performed to identify > 15 B-lines at discharge
as the best cut-off to predict readmission for HF during
follow-up with a sensitivity of 92.9 %, specificity of 68.6 %
negative predictive value of 98.3 %, positive predictive value
of 32.5 %, negative likelihood ratio of 0.1, positive likelihood
ratio of 2.96 (area under the curve 0.83, 95 % confidence
interval 0.74–0.92, p < .0001). The 6-month event-free
survival showed a significantly better outcome for those
patients with ≤ 15 B-lines at discharge, whereas a worse
outcome was observed in patients with > 15 B-lines at
discharge (log rank χ2 20.5, p < .0001) (Fig. 2). Table 3
shows the parameters that were significantly different
between patients with and without events. Predictors of
HF hospitalization by univariate and multivariate ana-
lysis are reported in Table 4. At multivariable analysis,
only a number of B-lines > 15 before discharge was an
independent predictor of HF readmission at 6 months
(hazard ratio [HR] 11.74; 95 % confidence interval [CI]
1.30–106.16).
When considering a follow-up of 3 months, the same
cut-off of > 15 B-lines predicted readmission for HF with a
sensitivity of 100 % and specificity of 64.8 %. The ROC
analysis identified > 20 B-lines at discharge as the best cut-
off to predict readmission for HF at 3 months follow-up,
with a sensitivity of 100 %, a specificity of 74.7 %, negative
predictive value of 100 %, positive predictive value of
28.1 %, negative likelihood ratio of 0, positive likelihood
ratio of 3.96 (area under the curve 0.88, 95 % confidence
interval 0.81-0.96, p < .0001). Kaplan-Meier curves depict-
ing the prognostic value of > 20 B-lines before discharge at
a 3 months follow-up are shown in Fig. 3 (log rank χ2
22.96, p < .0001).
Discussion
In patients admitted with AHF to a cardiology depart-
ment, the absence of significant pulmonary congestion
before discharge, assessed by lung ultrasound, identifies
a subgroup at a very low risk of being readmitted for
decompensated HF in the following 6 months.
Pathophysiology of persistent congestion
The role of persistent congestion at hospital discharge
is relevant in the outcome of patients with AHF. The
early post-discharge time interval immediately after
hospitalization, which is often addressed to as the
Fig 1 Individuals dynamic changes in admission-to-discharge B-lines
Fig 2 Kaplan-Meier survival curves in HF patients stratified according to the number of B-lines before discharge, at 6-months follow-up
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vulnerable phase [27], has been recognized as a crucial
moment in the management of AHF, when the major-
ity of events occur [28, 29]. Patients with HF die or
are hospitalized for different reasons, including ische-
mia, arrhythmias, worsened hemodynamics. However,
in the vast majority the underlying pathophysiology is
primarily related to increasing left ventricular filling
pressures [30]. In the continuum of the congestion cas-
cade in HF, it is important to distinguish the different
phases of congestion [5, 31]: increased left ventricular fill-
ing pressures represent a phase of hemodynamic conges-
tion, which is different from pulmonary, and from
systemic and clinical congestion. In this cascade, pulmon-
ary congestion more specifically refers to extravascular lung
water (EVLW). Patients with the same degree of LV filling
pressures may have significantly different degrees of pul-
monary congestion, from complete absence of EVLW to al-
veolar pulmonary edema. These differences rely on many
aspects, which are often difficult to be assessed, including
the integrity of alveolar-capillary membrane – that depends
also on the length of the disease -, the systemic inflamma-
tion status which may influence vascular permeability, and
lymphatic drainage. LUS evaluation of B-lines offers a spe-
cific visualization of pulmonary congestion [32], thus eas-
ily allowing a non-invasive and bedside assessment of the
degree of EVLW in any single patient. This information
adds to the assessment of hemodynamic congestion
that can be non-invasively performed through echo-
Doppler parameters. Natriuretic peptides, which are
very useful at all steps of the management of HF pa-
tients, reflect more hemodynamic than pulmonary
congestion. This can explain why natriuretic peptides
and B-lines are somehow correlated in relatively large
populations [15], but can provide very different infor-
mation in the single patient, one enhancing the value
of the other, especially in patients with natriuretic
peptides in the grey zone [16, 17].
It is worth highlighting that there is no standardized
method to assess pulmonary congestion in the clinical
arena [5]. Chest X-ray is the most widely used tool to
establish the presence and degree of EVLW, allowing a
visualization of the lungs in the context of the whole
chest. However, both sensitivity and specificity to detect
signs of pulmonary congestion are suboptimal. Nearly
20 % of patients with HF have a normal chest X-ray,
limiting overall sensitivity [21, 33].
Comparison with previous studies
The search for an optimal tool to predict rehospitalization
for HF has been going on for years. Some scores have been
proposed, although predictive models of HF hospitalization
are still not currently implemented in the clinical practice.
Most scores have been validated on chronic HF in ambula-
tory outpatients, and include clinical, biochemical and
sometimes instrumental data, such as the HFPSI (Heart
Failure Patient Severity Index) [34], the CHARM score
[35], and more recently the REDIN score [36].
Previous studies have demonstrated the prognostic
role of B-lines as an independent predictor of events in
patients admitted with dyspnea and/or chest pain, in
acute coronary syndromes, in hemodialysis, and in
chronic HF even when assessed by a hand-held ultra-
sound device [37–41]. However, these analysis refer to
admission exams and not to discharge, when the clinical
information derived from a timely assessment can be
relevant not only in a population-based approach, but
also in a patient-based risk assessment, useful for man-
agement decisions, including discharge therapy, diuretic
dosage, follow-up timing.
Clinical implications
In the last few years the use of B-lines in the management
of patient with acute and chronic HF has moved from the
research setting to the clinical arena, and its assessment is
now included in Recommendation papers [21, 42, 43].
Table 3 Different parameters in patients with and without






Male sex 62 (72 %) 11 (79 %) 0.61
Age (years) 70.3 ± 10.9 69.8 ± 0.51 0.87
NYHA class 2.7 ± 0.9 3.4 ± 0.9 0.02
SAP (mmHg) 126 ± 22 124 ± 140 0.79
Diabetes Mellitus (n, %) 31 (36 %) 8 (57 %) 0.14
Hypertension (n, %) 49 (58 %) 8 (57 %) 0.37
Creatinine (mg/dl) 1.3 ± 0.5 1.6 ± 1.2 0.09
Hemoglobin (g/dl) 13.0 ± 2.1 12.0 ± 2.4 0.10
CRP (mg/l) 1.4 ± 2.1 1.1 ± 1.3 0.56
NT-proBNP (ng/l) at
admission
5091 ± 5929 6203 ± 5821 0.57
NT-proBNP (ng/l) at
discharge
3065 ± 4103 3816 ± 2764 0.09
Ejection fraction (%) 37 ± 13 37 ± 19 0.99
Wall motion score index 1.85 ± 0.57 1.83 ± 0.68 0.88
Restrictive pattern (n, %) 22 (26 %) 1 (7 %) 0.25
TAPSE (mm) 16.8 ± 4.7 14.5 ± 4.2 0.14
PASP (mmHg) 48 ± 14 54 ± 15 0.20
Pericardial effusion (n, %) 7 (8 %) 2 (14 %) 0.51
Pleural effusion (n, %) 19 (23 %) 5 (36 %) 0.42
B-lines at admission 43 ± 43 79 ± 66 0.01
B-lines at discharge 17 ± 22 40 ± 24 <0.0001
NYHA New York Heart Association, SAP systolic arterial pressure, CRP C-reactive
protein, TAPSE tricuspid annular plane systolic excursion, PASP pulmonary
artery systolic pressure
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Our data shows that patients with persistent sonographic
pulmonary congestion have an increased risk for rehospi-
talization for HF in the next 6 months, but the main find-
ing of our study is the very low risk of readmission in
patients with ≤ 15 B-lines before discharge. Thus, assess-
ment of B-lines would allow for tailored discharge risk
stratification. While further studies are needed, persistent
presence of B-lines may be useful to titrate therapy as well as
to personalize discharge planning and timing of follow-up.
It is interesting to note that although both B-lines at
admission and at discharge are predictors of rehospitaliza-
tion at univariate analysis, B-lines at discharge have a higher
Table 4 Univariate and multivariate analysis to predict events (HF readmission at 6 months)
Univariate analysis Multivariate analysis
HR (95 % CI) p HR (95 % CI) p
Age a 0.99 (0.95 – 1.04) 0.88
NYHA class a 2.31 (1.16 – 4.60) 0.017 1.48 (0.63 – 3.49) 0.37
Diabetes Mellitus 2.19 (0.76 – 6.31) 0.15
Creatinine a 1.58 (0.90 – 2.76) 0.11
Hemoglobin a 0.77 (0.59 – 1.02) 0.07
Hemoglobin < 10 g/dl 5.75 (1.76 – 18.78) 0.004 3.96 (0.52 – 30.10) 0.52
NT-proBNP at admission a 1.01 (0.99 – 1.01) 0.54
NT-proBNP at discharge a 1.01 (0.99 – 1.01) 0.55
NT-proBNP at discharge > 1635 ng/l 10.65 (1.35 – 84.26) 0.025 3.98 (0.43 – 37.18) 0.23
Ejection fraction a 1.01 (0.96 – 1.04) 0.91
Wall motion score index a 0.88 (0.35 – 2.17) 0.77
Restrictive pattern 0.33 (0.04 – 2.72) 0.30
TAPSE a 0.91 (0.80 – 1.03) 0.13
PASP a 1.03 (0.99 – 1.07) 0.11
Pericardial effusion (n, %) 1.68 (0.38 – 7.51) 0.49
Pleural effusion (n, %) 1.67 (0.51 – 5.49) 0.39
B-lines at admission a 1.01 (1.01 – 1.02) 0.004
B-lines at admission > 50 5.83 (1.82 – 18.62) 0.003 4.87 (0.88 – 27.06) 0.07
B-lines at discharge a 1.03 (1.01 – 1.04) 0.001
B-lines at discharge > 15 24.12 (3.15 – 184.55) 0.002 11.74 (1.30 – 106.16) 0.028
NYHA New York Heart Association, TAPSE tricuspid annular plane systolic excursion, PASP pulmonary artery systolic pressure, HR hazard ratio, CI confidence interval
a = continuous variable
Fig 3 Kaplan-Meier survival curves in HF patients stratified according to the number of B-lines before discharge, at 3-months follow-up
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hazard ratio and are the only independent predictors of
events at multivariate analysis. The best cut-offs obtained
by ROC analysis to maximize accuracy are also different: at
admission a higher number of B-lines is needed to confer
an increased risk of events at 6-months, compared to dis-
charge. This is reasonable, given the dynamic behavior of
B-lines that can be highly responsive to treatment [44], and
may rapidly change even after the short time of a dialysis
session [25, 45], or increase significantly during the few mi-
nutes of a stress-echo test [46].
The possibility to count B-lines has been debated in
the past. B-lines are substantially rough ultrasound arti-
facts, but by now many studies have shown the good
correlations between the somehow “imprecise” number
of B-lines and more established parameters of increased
EVLW and decompensation [15, 17, 24, 25, 47–52]. In
the clinical routine, however, the eyeballing imaging of
B-lines (the whiter the image under the pleural line, the
more B-lines) can be enough to get quick but meaning-
ful information on the degree of pulmonary congestion.
Moreover, the possibility to implement specific software
which may aid in establishing the severity of B-lines,
would further simplify the process [53].
We found > 15 and > 20 B-lines to be the best cut-offs
to maximize accuracy in the prediction of HF readmission
at 6 and 3 months. This cut-offs, although derived from
independent statistical analysis, are consistent with previ-
ous studies showing that ≥ 15 B lines predicts decompen-
sation in outpatients with HF [54]. It is worth noting
however, that counting B-lines should not be equated to a
precise assessment such as dosing a metabolite, and a dif-
ference in a few B-lines is not of clinical importance. The
spatial distribution of B-lines and not only the absolute
number of B-lines should be taken into account: first, it is
known that a few B-lines, especially at pulmonary bases,
can be found in normal subjects [13]; then, a very small
number of B-lines found in many different scanning sites,
although yielding an absolute high total number, may be
less clinically relevant than many B-lines in a smaller
number of scanning sites. As with any other test, B-lines
should not be interpreted in isolation, but integrated with
the overall clinical picture.
Despite not being a sophisticated, high tech parameter,
this simple ultrasound biomarker seems to effectively help
in the management of patients with HF, in a very sustain-
able and patient-friendly approach.
Limitations
This is a single-centre study with a relatively small study
group of patients with HF of different aetiologies. This
limitation however reflects the potentialities of LUS B-
lines in different clinical scenarios, including patients with
HF due to acute coronary syndromes. Given the relatively
small study population, the number of events is also low.
However, the number of patients enrolled was determined
as sufficient according to sample size calculation. It should
be emphasized that B-lines are a non-specific sign of pul-
monary interstitial syndrome, which can be found also in
interstitial pulmonary fibrosis, interstitial pneumonia and
acute respiratory distress syndrome. This is crucial espe-
cially when using B-lines for the differential diagnosis of
dyspnoea. When B-lines are used to determine persistent
pulmonary congestion in patients with an already estab-
lished diagnosis of HF, this limitation is less relevant.
Interpreting B-lines not as a single image, but in a specific
clinical context, is the key to avoid gross misinterpretation
of this sign. When presence or persistence of B-lines is
totally unrelated to the clinical picture, caution should be
used and other causes of B-lines should be taken into ac-
count (pulmonary fibrosis in patients on amiodarone, non
cardiogenic pulmonary edema, interstitial lung disease).
Persistent pulmonary congestion can be related to the
dosage of pharmacological therapy, especially diuretics;
unfortunately, we did not add the specific dosage of
therapies administered during hospital stay in our study
population. Our findings should be confirmed in a lar-
ger multicentre study.
Conclusions
In AHF patients, persistent pulmonary congestion as
defined by ≥ 15 B lines strongly predicts rehospitalization
in the following 6-months. Absence or a mild degree of
B-lines identify a subgroup at extremely low risk to be
readmitted for AHF. Sonographic B-lines can be useful
not only for the differential diagnosis of acute dyspnea,
but also for the prognostic stratification of HF patients.
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